Su-Ning Chen Selected Research

Protein-Tyrosine Kinases (Tyrosine Kinase)

8/2013

[Clinical and experimental characteristics of 20 patients with acute myeloid leukemia with complex variant of t(8; 21)].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Su-Ning Chen Research Topics

Disease

11	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2023 - 08/2013
5	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 08/2020 - 04/2003
5	Leukemia 03/2018 - 08/2007
4	Acute Promyelocytic Leukemia 12/2024 - 08/2019
4	Philadelphia Chromosome 02/2024 - 08/2014
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 08/2014
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2023 - 11/2017
3	Neoplasms (Cancer) 01/2021 - 08/2007
3	Chromosome Aberrations (Chromosome Abnormalities) 10/2018 - 10/2013
2	Thalassemia 01/2021 - 12/2015
2	Hematologic Neoplasms (Hematological Malignancy) 12/2018 - 01/2013
2	Hematologic Diseases (Blood Diseases) 12/2018 - 08/2006
2	Graft vs Host Disease (Graft-Versus-Host Disease) 02/2008 - 08/2006
1	Agranulocytosis (Granulocytopenia) 12/2024
1	Tumor Lysis Syndrome 12/2024
1	Carcinogenesis 02/2024
1	Breast Neoplasms (Breast Cancer) 11/2023
1	Diarrhea 01/2023
1	Chronic Urticaria 01/2023
1	Asthma (Bronchial Asthma) 01/2023
1	Eosinophilia 01/2023
1	Hypereosinophilic Syndrome (Loeffler Endocarditis) 01/2023
1	Cough 01/2023
1	Pneumonia (Pneumonitis) 01/2023
1	Gastroesophageal Reflux (GERD) 07/2021
1	Disease Progression 01/2021
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2018
1	Infections 12/2017
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 12/2015
1	Megaloblastic Anemia 08/2013
1	Tuberculosis (Tuberculoses) 01/2013
1	Aspergillosis 12/2009

Drug/Important Bio-Agent (IBA)

4	Decitabine FDA Link 01/2021 - 01/2015
3	Imatinib Mesylate (Gleevec)FDA Link 02/2024 - 10/2018
2	Monoclonal AntibodiesIBA 01/2023 - 02/2008
2	Tyrosine Kinase InhibitorsIBA 01/2023 - 08/2014
2	Arsenic Trioxide (Trisenox)FDA Link 10/2022 - 10/2016
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2021 - 01/2018
2	Hemoglobins (Hemoglobin)IBA 01/2021 - 12/2015
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021 - 01/2018
2	fms-Like Tyrosine Kinase 3IBA 01/2020 - 12/2018
2	Proteins (Proteins, Gene)FDA Link 12/2018 - 11/2017
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2017 - 02/2008
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2008 - 08/2006
1	gilteritinibIBA 12/2024
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 02/2024
1	pseudolaric acid BIBA 11/2023
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 11/2023
1	Omalizumab (Xolair)FDA Link 01/2023
1	SteroidsIBA 01/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023
1	anti-IgE antibodiesIBA 01/2023
1	ArsenicIBA 10/2022
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 10/2022
1	avapritinibIBA 10/2022
1	Therapeutic UsesIBA 07/2021
1	xiaochaihuIBA 07/2021
1	Omeprazole (Prilosec)FDA LinkGeneric 07/2021
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 01/2021
1	Codon (Codons)IBA 01/2021
1	Chimeric Antigen ReceptorsIBA 01/2021
1	N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA 01/2021
1	ruxolitinibIBA 01/2020
1	arseniteIBA 08/2019
1	AnthracyclinesIBA 08/2019
1	AcidsIBA 08/2019
1	DNA (Deoxyribonucleic Acid)IBA 12/2018
1	hydrogen sulfite (bisulfite)IBA 12/2018
1	isocitrate dehydrogenase (NADP+)IBA 12/2018
1	MicroRNAs (MicroRNA)IBA 03/2018
1	A-factor (Streptomyces)IBA 03/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 12/2017
1	hemoglobin KolnIBA 12/2015
1	hemoglobin KenitraIBA 12/2015
1	hemoglobin SaitamaIBA 12/2015
1	hemoglobin SeattleIBA 12/2015
1	hemoglobin BushwickIBA 12/2015
1	HLA-DR Antigens (HLA-DR)IBA 04/2015
1	Phosphotransferases (Kinase)IBA 08/2014
1	Uracil-DNA GlycosidaseIBA 08/2014
1	CD34 Antigens (CD34 Antigen)IBA 10/2013
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 08/2013
1	CD AntigensIBA 08/2013
1	Differentiation AntigensIBA 08/2013
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 02/2008
1	Methotrexate (Mexate)FDA LinkGeneric 02/2008
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2007
1	Matrix Metalloproteinases (MMPs)IBA 08/2007

Therapy/Procedure

5	Therapeutics 12/2024 - 01/2018
5	Hematopoietic Stem Cell Transplantation 08/2020 - 08/2006
2	Drug Therapy (Chemotherapy) 01/2021 - 03/2018
2	Transplantation 12/2017 - 12/2009
1	Aftercare (After-Treatment) 07/2021
1	Secondary Prevention 07/2021
1	Stem Cell Transplantation 01/2021
1	Salvage Therapy 01/2021
1	Induction Chemotherapy 08/2019
1	Organ Transplantation 01/2013
1	Subcutaneous Injections 08/2007